Kumaraswamy Naidu Chitrala
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 5 | 2024 | 293 | 1.960 |
Why?
|
| Breast Neoplasms | 5 | 2024 | 1502 | 1.510 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2022 | 767 | 1.400 |
Why?
|
| Models, Molecular | 4 | 2019 | 808 | 1.070 |
Why?
|
| Estrogen Receptor alpha | 2 | 2019 | 111 | 1.060 |
Why?
|
| Carrier Proteins | 3 | 2019 | 305 | 1.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 213 | 1.000 |
Why?
|
| Genome-Wide Association Study | 8 | 2022 | 333 | 0.990 |
Why?
|
| Ligands | 4 | 2019 | 349 | 0.960 |
Why?
|
| Frontotemporal Dementia | 1 | 2023 | 4 | 0.930 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 128 | 0.890 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2021 | 389 | 0.890 |
Why?
|
| Gene Regulatory Networks | 3 | 2024 | 120 | 0.800 |
Why?
|
| Liver Neoplasms | 1 | 2024 | 190 | 0.790 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2021 | 12 | 0.780 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 807 | 0.720 |
Why?
|
| DNA Methylation | 2 | 2019 | 325 | 0.690 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 19 | 0.680 |
Why?
|
| Molecular Dynamics Simulation | 5 | 2019 | 133 | 0.680 |
Why?
|
| Phenotype | 5 | 2022 | 689 | 0.680 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 905 | 0.670 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2018 | 48 | 0.640 |
Why?
|
| Interleukin-15 | 1 | 2016 | 13 | 0.580 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2017 | 54 | 0.570 |
Why?
|
| Databases, Genetic | 1 | 2016 | 93 | 0.560 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 234 | 0.510 |
Why?
|
| Benzofurans | 1 | 2014 | 21 | 0.490 |
Why?
|
| Carcinogens | 1 | 2014 | 124 | 0.470 |
Why?
|
| Humans | 24 | 2024 | 37093 | 0.460 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 112 | 0.450 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 65 | 0.450 |
Why?
|
| Leukemia | 2 | 2023 | 56 | 0.430 |
Why?
|
| Pharmaceutical Preparations | 1 | 2013 | 75 | 0.420 |
Why?
|
| Computer Simulation | 1 | 2014 | 362 | 0.420 |
Why?
|
| Proteins | 1 | 2014 | 369 | 0.400 |
Why?
|
| Binding Sites | 3 | 2019 | 651 | 0.400 |
Why?
|
| Melanoma | 2 | 2022 | 96 | 0.390 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 1015 | 0.390 |
Why?
|
| Software | 1 | 2013 | 217 | 0.390 |
Why?
|
| Protein Binding | 3 | 2019 | 972 | 0.370 |
Why?
|
| Membrane Proteins | 1 | 2013 | 517 | 0.360 |
Why?
|
| Mice | 8 | 2023 | 5913 | 0.340 |
Why?
|
| Female | 9 | 2024 | 20969 | 0.290 |
Why?
|
| Molecular Conformation | 2 | 2019 | 152 | 0.280 |
Why?
|
| Protein Structure, Tertiary | 2 | 2018 | 408 | 0.260 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 803 | 0.260 |
Why?
|
| Protein Conformation | 2 | 2019 | 389 | 0.260 |
Why?
|
| Molecular Structure | 2 | 2019 | 492 | 0.240 |
Why?
|
| Aging | 2 | 2019 | 664 | 0.240 |
Why?
|
| Animals | 8 | 2023 | 15081 | 0.230 |
Why?
|
| Alleles | 2 | 2021 | 321 | 0.220 |
Why?
|
| Epigenesis, Genetic | 3 | 2021 | 219 | 0.220 |
Why?
|
| Gene Expression Profiling | 2 | 2024 | 626 | 0.220 |
Why?
|
| BRCA1 Protein | 1 | 2023 | 48 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 628 | 0.210 |
Why?
|
| Genotype | 2 | 2022 | 730 | 0.200 |
Why?
|
| Apolipoprotein E4 | 1 | 2022 | 47 | 0.200 |
Why?
|
| Calcium Signaling | 1 | 2022 | 101 | 0.200 |
Why?
|
| Interferon-gamma | 1 | 2022 | 250 | 0.200 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2021 | 26 | 0.200 |
Why?
|
| Esophageal Neoplasms | 1 | 2022 | 127 | 0.190 |
Why?
|
| DNA Damage | 1 | 2023 | 352 | 0.190 |
Why?
|
| Mutation, Missense | 1 | 2020 | 83 | 0.180 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2019 | 5 | 0.180 |
Why?
|
| Metalloendopeptidases | 1 | 2019 | 16 | 0.180 |
Why?
|
| Glutathione Transferase | 1 | 2019 | 88 | 0.170 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2019 | 42 | 0.170 |
Why?
|
| Blood Glucose | 1 | 2021 | 353 | 0.170 |
Why?
|
| Mice, Knockout | 2 | 2022 | 933 | 0.160 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2019 | 187 | 0.160 |
Why?
|
| Carbazoles | 1 | 2018 | 42 | 0.160 |
Why?
|
| Amino Acids | 1 | 2019 | 145 | 0.160 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 409 | 0.150 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2019 | 107 | 0.150 |
Why?
|
| Cholesterol | 2 | 2022 | 205 | 0.150 |
Why?
|
| Parkinson Disease | 1 | 2019 | 178 | 0.150 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 6 | 0.150 |
Why?
|
| Bacteroidetes | 1 | 2017 | 9 | 0.150 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2017 | 40 | 0.150 |
Why?
|
| Propionates | 1 | 2017 | 26 | 0.150 |
Why?
|
| Indoles | 1 | 2018 | 158 | 0.150 |
Why?
|
| Metagenomics | 1 | 2017 | 34 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 2019 | 249 | 0.150 |
Why?
|
| Urban Population | 1 | 2019 | 333 | 0.150 |
Why?
|
| Feces | 1 | 2017 | 111 | 0.140 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 171 | 0.140 |
Why?
|
| Gene Deletion | 1 | 2017 | 166 | 0.140 |
Why?
|
| Phosphorylation | 1 | 2019 | 928 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 935 | 0.130 |
Why?
|
| Middle Aged | 5 | 2022 | 10129 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 664 | 0.130 |
Why?
|
| Dioxins | 1 | 2014 | 8 | 0.130 |
Why?
|
| Mutation | 1 | 2019 | 1095 | 0.120 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 89 | 0.120 |
Why?
|
| Hypertension | 1 | 2021 | 796 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 172 | 0.110 |
Why?
|
| Depression | 1 | 2019 | 712 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1609 | 0.100 |
Why?
|
| Adult | 4 | 2019 | 11712 | 0.100 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1371 | 0.100 |
Why?
|
| Multifactorial Inheritance | 2 | 2021 | 19 | 0.100 |
Why?
|
| Lipids | 2 | 2022 | 235 | 0.100 |
Why?
|
| Male | 5 | 2019 | 20025 | 0.090 |
Why?
|
| Obesity | 1 | 2017 | 1067 | 0.080 |
Why?
|
| Aged | 3 | 2019 | 6741 | 0.060 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 6 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-abl | 1 | 2023 | 8 | 0.060 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2023 | 5 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2023 | 14 | 0.060 |
Why?
|
| BRCA2 Protein | 1 | 2023 | 37 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2022 | 76 | 0.050 |
Why?
|
| Epithelium | 1 | 2022 | 79 | 0.050 |
Why?
|
| Methylation | 1 | 2022 | 113 | 0.050 |
Why?
|
| Esophagus | 1 | 2022 | 42 | 0.050 |
Why?
|
| Linkage Disequilibrium | 1 | 2021 | 85 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 12 | 0.050 |
Why?
|
| Population Groups | 1 | 2021 | 56 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 2721 | 0.050 |
Why?
|
| Chromatin | 1 | 2022 | 169 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2022 | 230 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 259 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 77 | 0.050 |
Why?
|
| Interleukin-7 | 1 | 2020 | 7 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2021 | 90 | 0.050 |
Why?
|
| Genetics | 1 | 2020 | 9 | 0.050 |
Why?
|
| Glucose | 1 | 2022 | 230 | 0.050 |
Why?
|
| Genomics | 1 | 2022 | 223 | 0.050 |
Why?
|
| Genome, Human | 1 | 2021 | 135 | 0.050 |
Why?
|
| DNA | 1 | 2023 | 574 | 0.040 |
Why?
|
| Glucosylceramidase | 1 | 2019 | 7 | 0.040 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2019 | 12 | 0.040 |
Why?
|
| Calcium | 1 | 2022 | 480 | 0.040 |
Why?
|
| Sleep | 1 | 2021 | 152 | 0.040 |
Why?
|
| CpG Islands | 1 | 2019 | 97 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 121 | 0.040 |
Why?
|
| Cell Line | 1 | 2022 | 1354 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2022 | 384 | 0.040 |
Why?
|
| Cognition | 1 | 2022 | 398 | 0.040 |
Why?
|
| Longevity | 1 | 2019 | 147 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2021 | 646 | 0.040 |
Why?
|
| Disease Progression | 1 | 2019 | 601 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2019 | 753 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 885 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2017 | 177 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2022 | 2231 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 1067 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 1492 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 1378 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 571 | 0.030 |
Why?
|
| Macrophages | 1 | 2017 | 439 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 602 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2022 | 1908 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 2379 | 0.030 |
Why?
|
| Inflammation | 1 | 2017 | 618 | 0.030 |
Why?
|